Trials / Completed
CompletedNCT03941275
SelectSecure 3830 Lead Imaging
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 51 (actual)
- Sponsor
- Medtronic Cardiac Rhythm and Heart Failure · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
This study is designed to collect high-quality shoulder and intracardiac bi-plane fluoroscopic images during two standard arm motions on patients implanted with a market released SelectSecure 3830 lead for the purposes of developing a fracture reliability model.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Bi-plane fluoroscopy | In vivo acquisition of biplane cine radiographic images of the market released Medtronic SelectSecure 3830 pacing lead |
Timeline
- Start date
- 2019-05-24
- Primary completion
- 2020-11-03
- Completion
- 2021-11-15
- First posted
- 2019-05-07
- Last updated
- 2022-03-15
Locations
4 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03941275. Inclusion in this directory is not an endorsement.